ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary mRNA Vaccines Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33O19056
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Veterinary mRNA Vaccines Market Research Report 2025
BUY CHAPTERS

Global Veterinary mRNA Vaccines Market Research Report 2025

Code: QYRE-Auto-33O19056
Report
March 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ceva Animal Health
Merck Animal Health
Bayer
BioNTech
BioVenic
Moderna, Inc
Ruipu Biotechnology
Jinyu Bio-Technology
Areterna
Genvax Technologies
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Shanghai Rnacure Biopharma

Veterinary mRNA Vaccines Market Size

The global market for Veterinary mRNA Vaccines was valued at US$ 20.2 million in the year 2024 and is projected to reach a revised size of US$ 39.6 million by 2031, growing at a CAGR of 10.1% during the forecast period.

Veterinary mRNA Vaccines Market

Veterinary mRNA Vaccines Market

Veterinary mRNA vaccines are a new generation of vaccines designed to protect animals from infectious diseases using messenger RNA (mRNA) technology. These vaccines work by delivering synthetic mRNA into animal cells, instructing them to produce specific antigens that trigger an immune response without using live pathogens. Compared to traditional vaccines, mRNA vaccines offer advantages such as faster development, adaptability to emerging diseases, and the ability to target multiple pathogens. They are being developed for livestock, poultry, and companion animals to combat diseases like avian influenza, swine fever, and canine influenza, improving animal health and food security.
North American market for Veterinary mRNA Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Veterinary mRNA Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Veterinary mRNA Vaccines include Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary mRNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary mRNA Vaccines.
The Veterinary mRNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary mRNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary mRNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary mRNA Vaccines Market Report

Report Metric Details
Report Name Veterinary mRNA Vaccines Market
Accounted market size in year US$ 20.2 million
Forecasted market size in 2031 US$ 39.6 million
CAGR 10.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injectable Drug Administration
  • Non-invasive Drug Administration
Segment by Application
  • for Poultry
  • for Livestock
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, Shanghai Shen Lian Biomedical, Suzhou Kerui Meide Biomedical Technology, Shanghai Rnacure Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary mRNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary mRNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Veterinary mRNA Vaccines Market growing?

Ans: The Veterinary mRNA Vaccines Market witnessing a CAGR of 10.1% during the forecast period 2025-2031.

What is the Veterinary mRNA Vaccines Market size in 2031?

Ans: The Veterinary mRNA Vaccines Market size in 2031 will be US$ 39.6 million.

Who are the main players in the Veterinary mRNA Vaccines Market report?

Ans: The main players in the Veterinary mRNA Vaccines Market are Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, Shanghai Shen Lian Biomedical, Suzhou Kerui Meide Biomedical Technology, Shanghai Rnacure Biopharma

What are the Application segmentation covered in the Veterinary mRNA Vaccines Market report?

Ans: The Applications covered in the Veterinary mRNA Vaccines Market report are for Poultry, for Livestock, Others

What are the Type segmentation covered in the Veterinary mRNA Vaccines Market report?

Ans: The Types covered in the Veterinary mRNA Vaccines Market report are Injectable Drug Administration, Non-invasive Drug Administration

Recommended Reports

Veterinary Vaccines

Livestock & Poultry Health

mRNA & Advanced Vaccines

1 Veterinary mRNA Vaccines Market Overview
1.1 Product Definition
1.2 Veterinary mRNA Vaccines by Type
1.2.1 Global Veterinary mRNA Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injectable Drug Administration
1.2.3 Non-invasive Drug Administration
1.3 Veterinary mRNA Vaccines by Application
1.3.1 Global Veterinary mRNA Vaccines Market Value by Application (2024 VS 2031)
1.3.2 for Poultry
1.3.3 for Livestock
1.3.4 Others
1.4 Global Veterinary mRNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary mRNA Vaccines Revenue 2020-2031
1.4.2 Global Veterinary mRNA Vaccines Sales 2020-2031
1.4.3 Global Veterinary mRNA Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary mRNA Vaccines Market Competition by Manufacturers
2.1 Global Veterinary mRNA Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary mRNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary mRNA Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary mRNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary mRNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary mRNA Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Veterinary mRNA Vaccines, Date of Enter into This Industry
2.8 Global Veterinary mRNA Vaccines Market Competitive Situation and Trends
2.8.1 Global Veterinary mRNA Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary mRNA Vaccines Players Market Share by Revenue
2.8.3 Global Veterinary mRNA Vaccines Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary mRNA Vaccines Market Scenario by Region
3.1 Global Veterinary mRNA Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary mRNA Vaccines Sales by Region: 2020-2031
3.2.1 Global Veterinary mRNA Vaccines Sales by Region: 2020-2025
3.2.2 Global Veterinary mRNA Vaccines Sales by Region: 2026-2031
3.3 Global Veterinary mRNA Vaccines Revenue by Region: 2020-2031
3.3.1 Global Veterinary mRNA Vaccines Revenue by Region: 2020-2025
3.3.2 Global Veterinary mRNA Vaccines Revenue by Region: 2026-2031
3.4 North America Veterinary mRNA Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary mRNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary mRNA Vaccines Sales by Country (2020-2031)
3.4.3 North America Veterinary mRNA Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary mRNA Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary mRNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary mRNA Vaccines Sales by Country (2020-2031)
3.5.3 Europe Veterinary mRNA Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary mRNA Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary mRNA Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary mRNA Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary mRNA Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary mRNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary mRNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary mRNA Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Veterinary mRNA Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Veterinary mRNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary mRNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary mRNA Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary mRNA Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary mRNA Vaccines Sales by Type (2020-2031)
4.1.1 Global Veterinary mRNA Vaccines Sales by Type (2020-2025)
4.1.2 Global Veterinary mRNA Vaccines Sales by Type (2026-2031)
4.1.3 Global Veterinary mRNA Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Veterinary mRNA Vaccines Revenue by Type (2020-2031)
4.2.1 Global Veterinary mRNA Vaccines Revenue by Type (2020-2025)
4.2.2 Global Veterinary mRNA Vaccines Revenue by Type (2026-2031)
4.2.3 Global Veterinary mRNA Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary mRNA Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary mRNA Vaccines Sales by Application (2020-2031)
5.1.1 Global Veterinary mRNA Vaccines Sales by Application (2020-2025)
5.1.2 Global Veterinary mRNA Vaccines Sales by Application (2026-2031)
5.1.3 Global Veterinary mRNA Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Veterinary mRNA Vaccines Revenue by Application (2020-2031)
5.2.1 Global Veterinary mRNA Vaccines Revenue by Application (2020-2025)
5.2.2 Global Veterinary mRNA Vaccines Revenue by Application (2026-2031)
5.2.3 Global Veterinary mRNA Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary mRNA Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ceva Animal Health
6.1.1 Ceva Animal Health Company Information
6.1.2 Ceva Animal Health Description and Business Overview
6.1.3 Ceva Animal Health Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ceva Animal Health Veterinary mRNA Vaccines Product Portfolio
6.1.5 Ceva Animal Health Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Animal Health Veterinary mRNA Vaccines Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Areterna
6.3.1 Areterna Company Information
6.3.2 Areterna Description and Business Overview
6.3.3 Areterna Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Areterna Veterinary mRNA Vaccines Product Portfolio
6.3.5 Areterna Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Veterinary mRNA Vaccines Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 BioNTech
6.5.1 BioNTech Company Information
6.5.2 BioNTech Description and Business Overview
6.5.3 BioNTech Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioNTech Veterinary mRNA Vaccines Product Portfolio
6.5.5 BioNTech Recent Developments/Updates
6.6 Genvax Technologies
6.6.1 Genvax Technologies Company Information
6.6.2 Genvax Technologies Description and Business Overview
6.6.3 Genvax Technologies Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Genvax Technologies Veterinary mRNA Vaccines Product Portfolio
6.6.5 Genvax Technologies Recent Developments/Updates
6.7 BioVenic
6.7.1 BioVenic Company Information
6.7.2 BioVenic Description and Business Overview
6.7.3 BioVenic Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BioVenic Veterinary mRNA Vaccines Product Portfolio
6.7.5 BioVenic Recent Developments/Updates
6.8 Moderna
6.8.1 Moderna Company Information
6.8.2 Moderna Description and Business Overview
6.8.3 Moderna Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Moderna Veterinary mRNA Vaccines Product Portfolio
6.8.5 Moderna Recent Developments/Updates
6.9 Ruipu Biotechnology
6.9.1 Ruipu Biotechnology Company Information
6.9.2 Ruipu Biotechnology Description and Business Overview
6.9.3 Ruipu Biotechnology Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ruipu Biotechnology Veterinary mRNA Vaccines Product Portfolio
6.9.5 Ruipu Biotechnology Recent Developments/Updates
6.10 Jinyu Bio-technology
6.10.1 Jinyu Bio-technology Company Information
6.10.2 Jinyu Bio-technology Description and Business Overview
6.10.3 Jinyu Bio-technology Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jinyu Bio-technology Veterinary mRNA Vaccines Product Portfolio
6.10.5 Jinyu Bio-technology Recent Developments/Updates
6.11 Shanghai Shen Lian Biomedical
6.11.1 Shanghai Shen Lian Biomedical Company Information
6.11.2 Shanghai Shen Lian Biomedical Description and Business Overview
6.11.3 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Portfolio
6.11.5 Shanghai Shen Lian Biomedical Recent Developments/Updates
6.12 Suzhou Kerui Meide Biomedical Technology
6.12.1 Suzhou Kerui Meide Biomedical Technology Company Information
6.12.2 Suzhou Kerui Meide Biomedical Technology Description and Business Overview
6.12.3 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Portfolio
6.12.5 Suzhou Kerui Meide Biomedical Technology Recent Developments/Updates
6.13 Shanghai Rnacure Biopharma
6.13.1 Shanghai Rnacure Biopharma Company Information
6.13.2 Shanghai Rnacure Biopharma Description and Business Overview
6.13.3 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Portfolio
6.13.5 Shanghai Rnacure Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary mRNA Vaccines Industry Chain Analysis
7.2 Veterinary mRNA Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary mRNA Vaccines Production Mode & Process Analysis
7.4 Veterinary mRNA Vaccines Sales and Marketing
7.4.1 Veterinary mRNA Vaccines Sales Channels
7.4.2 Veterinary mRNA Vaccines Distributors
7.5 Veterinary mRNA Vaccines Customer Analysis
8 Veterinary mRNA Vaccines Market Dynamics
8.1 Veterinary mRNA Vaccines Industry Trends
8.2 Veterinary mRNA Vaccines Market Drivers
8.3 Veterinary mRNA Vaccines Market Challenges
8.4 Veterinary mRNA Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Ceva Animal Health
Merck Animal Health
Bayer
BioNTech
BioVenic
Moderna, Inc
Ruipu Biotechnology
Jinyu Bio-Technology
Areterna
Genvax Technologies
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Shanghai Rnacure Biopharma
List of Tables
 Table 1. Global Veterinary mRNA Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary mRNA Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary mRNA Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary mRNA Vaccines Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary mRNA Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary mRNA Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary mRNA Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary mRNA Vaccines Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary mRNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary mRNA Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary mRNA Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary mRNA Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary mRNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary mRNA Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary mRNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Veterinary mRNA Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary mRNA Vaccines Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Veterinary mRNA Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary mRNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary mRNA Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary mRNA Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary mRNA Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary mRNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Veterinary mRNA Vaccines Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Veterinary mRNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary mRNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary mRNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Veterinary mRNA Vaccines Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Veterinary mRNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary mRNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary mRNA Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Veterinary mRNA Vaccines Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Veterinary mRNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary mRNA Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary mRNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Veterinary mRNA Vaccines Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Veterinary mRNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary mRNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary mRNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Veterinary mRNA Vaccines Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Veterinary mRNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary mRNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary mRNA Vaccines Sales (K Dose) by Type (2020-2025)
 Table 51. Global Veterinary mRNA Vaccines Sales (K Dose) by Type (2026-2031)
 Table 52. Global Veterinary mRNA Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary mRNA Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary mRNA Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary mRNA Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary mRNA Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary mRNA Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary mRNA Vaccines Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Veterinary mRNA Vaccines Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Veterinary mRNA Vaccines Sales (K Dose) by Application (2020-2025)
 Table 61. Global Veterinary mRNA Vaccines Sales (K Dose) by Application (2026-2031)
 Table 62. Global Veterinary mRNA Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary mRNA Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary mRNA Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary mRNA Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary mRNA Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary mRNA Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary mRNA Vaccines Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Veterinary mRNA Vaccines Price (US$/Dose) by Application (2026-2031)
 Table 70. Ceva Animal Health Company Information
 Table 71. Ceva Animal Health Description and Business Overview
 Table 72. Ceva Animal Health Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Ceva Animal Health Veterinary mRNA Vaccines Product
 Table 74. Ceva Animal Health Recent Developments/Updates
 Table 75. Merck Animal Health Company Information
 Table 76. Merck Animal Health Description and Business Overview
 Table 77. Merck Animal Health Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Merck Animal Health Veterinary mRNA Vaccines Product
 Table 79. Merck Animal Health Recent Developments/Updates
 Table 80. Areterna Company Information
 Table 81. Areterna Description and Business Overview
 Table 82. Areterna Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Areterna Veterinary mRNA Vaccines Product
 Table 84. Areterna Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Bayer Veterinary mRNA Vaccines Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. BioNTech Company Information
 Table 91. BioNTech Description and Business Overview
 Table 92. BioNTech Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. BioNTech Veterinary mRNA Vaccines Product
 Table 94. BioNTech Recent Developments/Updates
 Table 95. Genvax Technologies Company Information
 Table 96. Genvax Technologies Description and Business Overview
 Table 97. Genvax Technologies Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Genvax Technologies Veterinary mRNA Vaccines Product
 Table 99. Genvax Technologies Recent Developments/Updates
 Table 100. BioVenic Company Information
 Table 101. BioVenic Description and Business Overview
 Table 102. BioVenic Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. BioVenic Veterinary mRNA Vaccines Product
 Table 104. BioVenic Recent Developments/Updates
 Table 105. Moderna Company Information
 Table 106. Moderna Description and Business Overview
 Table 107. Moderna Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Moderna Veterinary mRNA Vaccines Product
 Table 109. Moderna Recent Developments/Updates
 Table 110. Ruipu Biotechnology Company Information
 Table 111. Ruipu Biotechnology Description and Business Overview
 Table 112. Ruipu Biotechnology Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Ruipu Biotechnology Veterinary mRNA Vaccines Product
 Table 114. Ruipu Biotechnology Recent Developments/Updates
 Table 115. Jinyu Bio-technology Company Information
 Table 116. Jinyu Bio-technology Description and Business Overview
 Table 117. Jinyu Bio-technology Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Jinyu Bio-technology Veterinary mRNA Vaccines Product
 Table 119. Jinyu Bio-technology Recent Developments/Updates
 Table 120. Shanghai Shen Lian Biomedical Company Information
 Table 121. Shanghai Shen Lian Biomedical Description and Business Overview
 Table 122. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product
 Table 124. Shanghai Shen Lian Biomedical Recent Developments/Updates
 Table 125. Suzhou Kerui Meide Biomedical Technology Company Information
 Table 126. Suzhou Kerui Meide Biomedical Technology Description and Business Overview
 Table 127. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product
 Table 129. Suzhou Kerui Meide Biomedical Technology Recent Developments/Updates
 Table 130. Shanghai Rnacure Biopharma Company Information
 Table 131. Shanghai Rnacure Biopharma Description and Business Overview
 Table 132. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product
 Table 134. Shanghai Rnacure Biopharma Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Veterinary mRNA Vaccines Distributors List
 Table 138. Veterinary mRNA Vaccines Customers List
 Table 139. Veterinary mRNA Vaccines Market Trends
 Table 140. Veterinary mRNA Vaccines Market Drivers
 Table 141. Veterinary mRNA Vaccines Market Challenges
 Table 142. Veterinary mRNA Vaccines Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary mRNA Vaccines
 Figure 2. Global Veterinary mRNA Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary mRNA Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Injectable Drug Administration Product Picture
 Figure 5. Non-invasive Drug Administration Product Picture
 Figure 6. Global Veterinary mRNA Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Veterinary mRNA Vaccines Market Share by Application: 2024 & 2031
 Figure 8. for Poultry
 Figure 9. for Livestock
 Figure 10. Others
 Figure 11. Global Veterinary mRNA Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Veterinary mRNA Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Veterinary mRNA Vaccines Sales (2020-2031) & (K Dose)
 Figure 14. Global Veterinary mRNA Vaccines Average Price (US$/Dose) & (2020-2031)
 Figure 15. Veterinary mRNA Vaccines Report Years Considered
 Figure 16. Veterinary mRNA Vaccines Sales Share by Manufacturers in 2024
 Figure 17. Global Veterinary mRNA Vaccines Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Veterinary mRNA Vaccines Players: Market Share by Revenue in Veterinary mRNA Vaccines in 2024
 Figure 19. Veterinary mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Veterinary mRNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Veterinary mRNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 22. North America Veterinary mRNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 23. United States Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Veterinary mRNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 26. Europe Veterinary mRNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Veterinary mRNA Vaccines Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Veterinary mRNA Vaccines Revenue Market Share by Region (2020-2031)
 Figure 34. China Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Veterinary mRNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Veterinary mRNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Veterinary mRNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Veterinary mRNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Veterinary mRNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Veterinary mRNA Vaccines by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Veterinary mRNA Vaccines by Type (2020-2031)
 Figure 54. Global Veterinary mRNA Vaccines Price (US$/Dose) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Veterinary mRNA Vaccines by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Veterinary mRNA Vaccines by Application (2020-2031)
 Figure 57. Global Veterinary mRNA Vaccines Price (US$/Dose) by Application (2020-2031)
 Figure 58. Veterinary mRNA Vaccines Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Veterinary Vaccine Market
Global Veterinary Vaccination Market Research Report 2025
Global Livestock Animal Vaccination Market Research Report 2025
Global Veterinary Biological Vaccines Market Research Report 2025
Global Livestock Animal Vaccines Market Research Report 2024
Global Livestock Vaccines Market Research Report 2025
Global Poultry and Livestock Vaccines Market Research Report 2025
Global Livestock mRNA Vaccines Market Research Report 2025
Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Vaccines Therapeutics Market Research Report 2024
Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Therapy Market Research Report 2024
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030
Animal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Agricultural Animal Vaccine Market Insights Forecast to 2030
Veterinary Autogenous Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Vaccine Raw Materials Market Research Report 2024
Vaccines for Livestock Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions